Assignee
NEOVACS
FR17 patents
Top patents by PatentIndex Score
US6093405AJul 25, 2000
Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines
NEOVACS55 citations95
US6132721AOct 17, 2000
Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
NEOVACS20 citations92
US6420141B1Jul 16, 2002
Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids
NEOVACS17 citations88
US6200575B1Mar 13, 2001
Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
NEOVACS18 citations83
US7314629B2Jan 1, 2008
Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus
NEOVACS15 citations82
US7022482B2Apr 4, 2006
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses
NEOVACS14 citations79
US6878370B1Apr 12, 2005
Chemically modified TNF-α
NEOVACS7 citations73
US6455045B1Sep 24, 2002
Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them
NEOVACS13 citations73
US7022326B1Apr 4, 2006
Carboxymethylated retroviral regulatory proteins and interferon-α
NEOVACS9 citations69
US7887811B2Feb 15, 2011
Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein
NEOVACS2 citations60
US7351554B2Apr 1, 2008
Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's
NEOVACS0 citations51
US7015016B2Mar 21, 2006
Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA's
NEOVACS0 citations51
US8372388B2Feb 12, 2013
Method for preparing a stable TNF-α vaccine
NEOVACS0 citations49
US7972603B2Jul 5, 2011
Stable immunogenic product comprising antigenic heterocomplexes
NEOVACS0 citations47
US7504479B2Mar 17, 2009
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses
NEOVACS0 citations47
US12059457B2Aug 13, 2024
Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity
NEOVACS0 citations46
US6228890B1May 8, 2001
Use of alicyclic diamines as immunomodulators
NEOVACS1 citations40